Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia-Reference-Cited by-同舟云学术

Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia

Published:2023-01 Issue:1 Volume:41 Page:164-180.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Wang Eric,Pineda Jose Mario Bello,Kim Won Jun,Chen Sisi,Bourcier Jessie,Stahl Maximilian,Hogg Simon J.,Bewersdorf Jan Phillipp,Han Cuijuan,Singer Michael E.,Cui Daniel,Erickson Caroline E.,Tittley Steven M.,Penson Alexander V.,Knorr Katherine,Stanley Robert F.,Rahman Jahan,Krishnamoorthy Gnana,Fagin James A.,Creger Emily,McMillan Elizabeth,Mak Chi-Ching,Jarvis Matthew,Bossard Carine,Beaupre Darrin M.,Bradley Robert K.,Abdel-Wahab Omar^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference108 articles.

1. Acute myeloid leukaemia in adults;Ferrara;Lancet,2013

2. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges;Short;Cancer Discov.,2020

3. Very poor long-term survival in past and more recent studies for relapsed AML patients: the ECOG-ACRIN experience;Ganzel;Am. J. Hematol.,2018

4. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;J. Clin. Oncol.,2005

5. The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells;Nechiporuk;Cancer Discov.,2019

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma;Journal of Experimental Medicine;2024-09-05

2. Cell death pathways: molecular mechanisms and therapeutic targets for cancer;MedComm;2024-09

3. TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells;Nature Communications;2024-08-28

4. Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia;Proceedings of the National Academy of Sciences;2024-08-13

5. RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness;2024-07-10